XenoPort Awarded United States Patent Directed To Composition And Formulations Of ... TheStreet.com (press release) ... preclinical animal studies that compared molar equivalent doses of XP23829 to dimethyl fumarate (DMF), another prodrug of MMF, XP23829 incontestible a greater degree of efficacy in animal models of both multiple pathology (MS) and psoriasis . and more » Link To Article
No comments:
Post a Comment